rs760874290
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_000369.5(TSHR):āc.394G>Cā(p.Gly132Arg) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.00000808 in 1,609,618 control chromosomes in the GnomAD database, with no homozygous occurrence. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000033 ( 0 hom., cov: 33)
Exomes š: 0.0000055 ( 0 hom. )
Consequence
TSHR
NM_000369.5 missense, splice_region
NM_000369.5 missense, splice_region
Scores
4
9
6
Splicing: ADA: 0.9796
2
Clinical Significance
Conservation
PhyloP100: 5.93
Genes affected
TSHR (HGNC:12373): (thyroid stimulating hormone receptor) The protein encoded by this gene is a membrane protein and a major controller of thyroid cell metabolism. The encoded protein is a receptor for thyrothropin and thyrostimulin, and its activity is mediated by adenylate cyclase. Defects in this gene are a cause of several types of hyperthyroidism. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSHR | NM_000369.5 | c.394G>C | p.Gly132Arg | missense_variant, splice_region_variant | 5/10 | ENST00000298171.7 | NP_000360.2 | |
LOC101928462 | XR_001751022.2 | n.881+2512C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSHR | ENST00000298171.7 | c.394G>C | p.Gly132Arg | missense_variant, splice_region_variant | 5/10 | 1 | NM_000369.5 | ENSP00000298171 | P1 | |
ENST00000646052.2 | n.904+2512C>G | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes AF: 0.0000330 AC: 5AN: 151670Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
5
AN:
151670
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000402 AC: 10AN: 248890Hom.: 0 AF XY: 0.0000445 AC XY: 6AN XY: 134716
GnomAD3 exomes
AF:
AC:
10
AN:
248890
Hom.:
AF XY:
AC XY:
6
AN XY:
134716
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1457948Hom.: 0 Cov.: 30 AF XY: 0.00000689 AC XY: 5AN XY: 725494
GnomAD4 exome
AF:
AC:
8
AN:
1457948
Hom.:
Cov.:
30
AF XY:
AC XY:
5
AN XY:
725494
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000330 AC: 5AN: 151670Hom.: 0 Cov.: 33 AF XY: 0.0000270 AC XY: 2AN XY: 74018
GnomAD4 genome
AF:
AC:
5
AN:
151670
Hom.:
Cov.:
33
AF XY:
AC XY:
2
AN XY:
74018
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
4
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Familial gestational hyperthyroidism Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 26, 2024 | - - |
TSHR-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | - | This variant has been previously reported as a de novo compound heterozygous and homozygous change in patients with congenital nongoitrous hypothyroidism-1 (CHNG1) who exhibited increased levels of plasma TSH and low levels of thyroid hormone in infancy (PMID: 21707688, 19158199). Functional studies showed that the presence of the (p.Gly132Arg) variant resulted in reduced binding activity and impaired TSH-induced cAMP production (26% of wild type) without any significant reduction in expression level (PMID: 19158199). The c.394G>C (p.Gly132Arg) variant is present in the heterozygous state in the gnomAD population database at a frequency of 0.004% (12/280224) and is absent in the homozygous state, thus is presumed to be rare. Based on the available evidence, the c.394G>C (p.Gly132Arg) variant is classified as Likely Pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jan 13, 2016 | The G132R variant in the TSHR gene has been reported previously in association with congenital hypothyroidism (Lee et al., 2011; Narumi et al., 2011). And, functional characterization of the G132R variant indicates a disruption in receptor function (Narumi et al., 2009). The G132R variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project; however, data from ethnically-matched control individuals were not available to assess for a population-specific benign variant. The G132R variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The G132R variant is a strong candidate for a pathogenic variant, however the possibility it may be a rare benign variant cannot be excluded. - |
Hypothyroidism due to TSH receptor mutations Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | The TSHR c.394G>C (p.Gly132Arg) missense variant has been reported in at least three studies in which it is found in a total of six patients with congenital hypothyroidism, including in one in a homozygous state, in two in a compound heterozygous state, in two in a heterozygous state, and in a heterozygous state in one patient who also carried a missense variant in another congenital hypothyroidism-associated gene (Narumi et al. 2009; Lee et al. 2011; Jin et al. 2014). The majority of these studies, however, did not screen for all the known causal genes. The p.Gly132Arg variant was absent from 100 controls, but is reported at a frequency of 0.00047 in the East Asian population of the Exome Aggregation Consortium. Functional studies in COS-7 cells showed that the p.Gly132Arg variant protein was expressed at a level comparable to that of the wild type protein but displayed severely reduced binding activity and impaired TSH-induced cAMP production (26% of wild type) (Narumi et al. 2009). The evidence for this variant is limited. The p.Gly132Arg variant is therefore classified as likley pathogenic for congenital hypothyroidism. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Ovarian cancer Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory of Molecular Epidemiology of Birth Defects, West China Second University Hospital, Sichuan University | Jan 01, 2022 | - - |
Familial hyperthyroidism due to mutations in TSH receptor Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 28, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Pathogenic
DEOGEN2
Benign
.;.;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;N;.;.;N
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;D;N;D;D
REVEL
Pathogenic
Sift
Benign
T;D;T;D;D
Sift4G
Benign
T;T;T;T;T
Polyphen
0.95
.;P;.;.;.
Vest4
MutPred
Gain of MoRF binding (P = 0.0221);Gain of MoRF binding (P = 0.0221);Gain of MoRF binding (P = 0.0221);Gain of MoRF binding (P = 0.0221);Gain of MoRF binding (P = 0.0221);
MVP
MPC
ClinPred
T
GERP RS
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at